Literature DB >> 22156513

Multiple layers of CD80/86-dependent costimulatory activity regulate primary, memory, and secondary lymphocytic choriomeningitis virus-specific T cell immunity.

Jens Eberlein1, Bennett Davenport, Tom T Nguyen, Francisco Victorino, Tim Sparwasser, Dirk Homann.   

Abstract

The lymphocytic choriomeningitis virus (LCMV) system constitutes one of the most widely used models for the study of infectious disease and the regulation of virus-specific T cell immunity. However, with respect to the activity of costimulatory and associated regulatory pathways, LCMV-specific T cell responses have long been regarded as relatively independent and thus distinct from the regulation of T cell immunity directed against many other viral pathogens. Here, we have reevaluated the contribution of CD28-CD80/86 costimulation in the LCMV system by use of CD80/86-deficient mice, and our results demonstrate that a disruption of CD28-CD80/86 signaling compromises the magnitude, phenotype, and/or functionality of LCMV-specific CD8(+) and/or CD4(+) T cell populations in all stages of the T cell response. Notably, a profound inhibition of secondary T cell immunity in LCMV-immune CD80/86-deficient mice emerged as a composite of both defective memory T cell development and a specific requirement for CD80 but not CD86 in the recall response, while a related experimental scenario of CD28-dependent yet CD80/86-independent secondary CD8(+) T cell immunity suggests the existence of a CD28 ligand other than CD80/86. Furthermore, we provide evidence that regulatory T cells (T(REG)s), the homeostasis of which is altered in CD80/86(-/-) mice, contribute to restrained LCMV-specific CD8(+) T cell responses in the presence of CD80/86. Our observations can therefore provide a more coherent perspective on CD28-CD80/86 costimulation in antiviral T cell immunity that positions the LCMV system within a shared context of multiple defects that virus-specific T cells acquire in the absence of CD28-CD80/86 costimulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22156513      PMCID: PMC3302393          DOI: 10.1128/JVI.05949-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  81 in total

Review 1.  T cell memory.

Authors:  Jonathan Sprent; Charles D Surh
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

2.  B7 costimulation plays an important role in protection from herpes simplex virus type 2-mediated pathology.

Authors:  Lydia G Thebeau; Lynda A Morrison
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

3.  Role of CD28 co-stimulation in generation and maintenance of virus-specific T cells.

Authors:  Jeanette E Christensen; Jan P Christensen; Nanna N Kristensen; Nils J V Hansen; Anette Stryhn; Allan R Thomsen
Journal:  Int Immunol       Date:  2002-07       Impact factor: 4.823

4.  CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells.

Authors:  Dirk Homann; Angelika Jahreis; Tom Wolfe; Anna Hughes; Bryan Coon; Marianne J B van Stipdonk; Kiley R Prilliman; Stephen P Schoenberger; Matthias G von Herrath
Journal:  Immunity       Date:  2002-03       Impact factor: 31.745

5.  Cutting edge: persistent viral infection prevents tolerance induction and escapes immune control following CD28/CD40 blockade-based regimen.

Authors:  Matthew A Williams; Thandi M Onami; Andrew B Adams; Megan M Durham; Thomas C Pearson; Rafi Ahmed; Christian P Larsen
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

6.  CD28(-/-) mice show defects in cellular and humoral immunity but are able to control infection with murine gammaherpesvirus 68.

Authors:  Bong Joo Lee; Su Khoh Reiter; Mandy Anderson; Sally R Sarawar
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

7.  In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses.

Authors:  E Scott Halstead; Yvonne M Mueller; John D Altman; Peter D Katsikis
Journal:  Nat Immunol       Date:  2002-05-20       Impact factor: 25.606

8.  Antibody-mediated control of persistent gamma-herpesvirus infection.

Authors:  In-Jeong Kim; Emilio Flaño; David L Woodland; Marcia A Blackman
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

9.  Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection.

Authors:  Edward M Bertram; Peggy Lau; Tania H Watts
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

10.  Mice deficient in perforin, CD4+ T cells, or CD28-mediated signaling maintain the typical immunodominance hierarchies of CD8+ T-cell responses to influenza virus.

Authors:  Weisan Chen; Jack R Bennink; Phillip A Morton; Jonathan W Yewdell
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more
  15 in total

1.  CD28 days later: Resurrecting costimulation for CD8(+) memory T cells.

Authors:  Verena van der Heide; Dirk Homann
Journal:  Eur J Immunol       Date:  2016-07       Impact factor: 5.532

2.  CD4⁺ and CD8⁺ T cell-dependent antiviral immunity requires STIM1 and STIM2.

Authors:  Patrick J Shaw; Carl Weidinger; Martin Vaeth; Kevin Luethy; Susan M Kaech; Stefan Feske
Journal:  J Clin Invest       Date:  2014-08-26       Impact factor: 14.808

3.  Chemokine Signatures of Pathogen-Specific T Cells I: Effector T Cells.

Authors:  Jens Eberlein; Bennett Davenport; Tom T Nguyen; Francisco Victorino; Kevin Jhun; Verena van der Heide; Maxim Kuleshov; Avi Ma'ayan; Ross Kedl; Dirk Homann
Journal:  J Immunol       Date:  2020-09-18       Impact factor: 5.422

4.  Chikungunya Virus Evades Antiviral CD8+ T Cell Responses To Establish Persistent Infection in Joint-Associated Tissues.

Authors:  Bennett J Davenport; Christopher Bullock; Mary K McCarthy; David W Hawman; Kenneth M Murphy; Ross M Kedl; Michael S Diamond; Thomas E Morrison
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

5.  Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent.

Authors:  Alice O Kamphorst; Andreas Wieland; Tahseen Nasti; Shu Yang; Ruan Zhang; Daniel L Barber; Bogumila T Konieczny; Candace Z Daugherty; Lydia Koenig; Ke Yu; Gabriel L Sica; Arlene H Sharpe; Gordon J Freeman; Bruce R Blazar; Laurence A Turka; Taofeek K Owonikoko; Rathi N Pillai; Suresh S Ramalingam; Koichi Araki; Rafi Ahmed
Journal:  Science       Date:  2017-03-09       Impact factor: 47.728

6.  Chemokine Signatures of Pathogen-Specific T Cells II: Memory T Cells in Acute and Chronic Infection.

Authors:  Bennett Davenport; Jens Eberlein; Tom T Nguyen; Francisco Victorino; Verena van der Heide; Maxim Kuleshov; Avi Ma'ayan; Ross Kedl; Dirk Homann
Journal:  J Immunol       Date:  2020-09-18       Impact factor: 5.422

7.  B7-1/B7-2 blockade overrides the activation of protective CD8 T cells stimulated in the absence of Foxp3+ regulatory T cells.

Authors:  James M Ertelt; Esra Z Buyukbasaran; Tony T Jiang; Jared H Rowe; Lijun Xin; Sing Sing Way
Journal:  J Leukoc Biol       Date:  2013-06-06       Impact factor: 4.962

Review 8.  The diverse functions of the PD1 inhibitory pathway.

Authors:  Arlene H Sharpe; Kristen E Pauken
Journal:  Nat Rev Immunol       Date:  2017-11-13       Impact factor: 53.106

9.  High efficiency of antiviral CD4(+) killer T cells.

Authors:  Steven K Hildemann; Jens Eberlein; Bennett Davenport; Tom T Nguyen; Francisco Victorino; Dirk Homann
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

Review 10.  Co-Stimulatory Blockade of the CD28/CD80-86/CTLA-4 Balance in Transplantation: Impact on Memory T Cells?

Authors:  Simon Ville; Nicolas Poirier; Gilles Blancho; Bernard Vanhove
Journal:  Front Immunol       Date:  2015-08-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.